Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth Read more
Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy Read more
ADHD Therapeutics Market to Surpass USD 23.89 Billion by 2035, Driven by Rising ADHD Prevalence and Expanding Mental Health Awareness – SNS Insider Read more
WANPY® XIAOJINDUN : The First Chinese Pet Food Staple Line with Full SGS Testing Against China-EU-US-Japan Export Standards Read more
mRNA Therapeutics Market Size to Surpass USD 78.09 Billion by 2035 Caused by the Increasing Investment in Genetic Medicine Research Globally | SNS Insider Read more
Yuanbao Inc. to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, March 18, 2026 Read more
UCLOUDLINK GROUP INC. to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 Read more